Search research articles
Contact Us
Filters
Showing results (181-190 of 237) with videos related to
Page
of 24
Sort By:
The Journal of Pathology
|
January 16, 2010
Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas
Monica Huszar, Marco Pfeifer, Uwe Schirmer, et al.
Breast (Edinburgh, Scotland)
|
February 17, 2020
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT
Guenther G Steger, Daniel Egle, Rupert Bartsch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2021
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma
Nicole Concin, François Planchamp, Nadeem R Abu-Rustum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study
Mani Nassir, Jun Guan, Hrvoje Luketina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 7, 2023
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial
Florian Heitz, Christian Marth, Stéphanie Henry, et al.
The Lancet. Oncology
|
February 24, 2019
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Gnant, Georg Pfeiler, Günther G Steger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2020
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey
Stefano Greggi, Francesca Falcone, Cono Scaffa, et al.
Journal of the National Cancer Institute
|
December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
Céline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 1, 2019
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
Denis Querleu, François Planchamp, Luis Chiva, et al.
The Lancet. Oncology
|
August 23, 2008
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
Michael Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 237) with videos related to
Sort By:
Page
of 24
The Journal of Pathology
|
January 16, 2010
Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas
Monica Huszar, Marco Pfeifer, Uwe Schirmer, et al.
Breast (Edinburgh, Scotland)
|
February 17, 2020
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT
Guenther G Steger, Daniel Egle, Rupert Bartsch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2021
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma
Nicole Concin, François Planchamp, Nadeem R Abu-Rustum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study
Mani Nassir, Jun Guan, Hrvoje Luketina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 7, 2023
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial
Florian Heitz, Christian Marth, Stéphanie Henry, et al.
The Lancet. Oncology
|
February 24, 2019
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Gnant, Georg Pfeiler, Günther G Steger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2020
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey
Stefano Greggi, Francesca Falcone, Cono Scaffa, et al.
Journal of the National Cancer Institute
|
December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
Céline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 1, 2019
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
Denis Querleu, François Planchamp, Luis Chiva, et al.
The Lancet. Oncology
|
August 23, 2008
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
Michael Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, et al.
Page
of 24